Chemotherapy for Malignant Mixed Müllerian Tumors of the Ovary
- 30 November 2000
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 79 (2), 196-200
- https://doi.org/10.1006/gyno.2000.5956
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Malignant mixed mesodermal tumors of the ovaryPublished by Wolters Kluwer Health ,2000
- Primary ovarian sarcomaCancer, 1998
- Mesna, Doxorubicin, Ifosfamide, and Dacarbazine Chemotherapy for Ovarian Mixed Müllerian Sarcoma: Report of Four CasesGynecologic Oncology, 1995
- A Phase II Trial of Ifosfamide and Mesna in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Ovary Previously Treated with Platinum-Based Chemotherapy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1994
- Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapyGynecologic Oncology, 1990
- Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovaryGynecologic Oncology, 1989
- A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A gynecologic oncology group studyGynecologic Oncology, 1984
- Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapyCancer, 1983
- Malignant Mixed Mesodermal Tumors and Carcinosarcoma of the OvaryObstetrical & Gynecological Survey, 1983
- Carcinosarcomas and mixed mesodermal tumors of the ovaryCancer, 1971